All In Biotech

Drug Trial Radar · NCT03738475

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

A Randomized, Double-blind, Placebo-controlled Study of the Safety, Pharmacodynamics, Efficacy, and Pharmacokinetics of TIMP-GLIA in Subjects With Well-controlled Celiac Disease Undergoing Oral Gluten Challenge

Last checked: Nov 19, 2026Latest source record: Aug 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

34

Actual

Start

Nov 11, 2018

Primary completion

Jun 24, 2019

Study completion Jul 22, 2019

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
Collaborators
COUR Pharmaceutical Development Company, Inc.
First posted
Nov 13, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Subjects enrolled in this study will be evaluated for immune responses and histological changes in the small bowel following 2 doses of TIMP-GLIA or placebo and a 14-day oral gluten challenge.

Conditions

  • Celiac Disease

Interventions

  • TIMP-GLIADrug

    8 mg/kg up to a maximum of 650 mg administered intravenously on days 1 and 8.

  • PlaceboDrug

    Administered intravenously on days 1 and 8.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Interferon-Gamma Spot Forming Units (IFN-gamma SFUs) in a Gliadin-specific Enzyme-linked Immunospot (ELISpot) at Day 20Time frame: Baseline (Day 15/Day 1), Day 20

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Advanced Clinical Research

    Meridian, Idaho

  • Indianapolis Gastroenterology Research Foundation

    Indianapolis, Indiana

  • Beth Isreal Deaconess Medical Center

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • Prism Clinical Research

    Saint Paul, Minnesota

  • Rapid Medical Research

    Beachwood, Ohio

  • Advanced Clinical Research

    West Jordan, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.